Kashefi Parviz, Abbasi Saeed, Kiani Koosha, Khajoei Maryam Khalifehsoltani, Akbari Mojtaba
Department of Anesthesia and Intensive Care, Alzahra University Hospital, Isfahan University of Medical Sciences, Isfahan, Iran.
Isfahan Endocrine and Metabolism Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
J Res Med Sci. 2024 Aug 2;29:48. doi: 10.4103/jrms.jrms_913_22. eCollection 2024.
Apnea testing is mandatory to confirm brain death; however, it is unsafe for patients who have substantial hypoxemia without ventilator support. We used a new modified apnea test without the need to disconnect the patient from the ventilator in the present study and compared the outcomes and complications of the new method to the widely used old method.
The current study was conducted on people suspected of having brain death. Both the old and new apnea tests were carried out on the same individual. In the new modified method, instead of hyperventilating and then separating the brain death from the ventilator, the induced hypercapnia method was used, and instead of performing repeated arterial blood gas (ABG), the target ETCO was obtained, and at the time of the target ETCO, ABG was also checked followed by comparing ETCO with PaCO.
Thirty patients, including 25 (83.3%) males and 5 (16.75%) females, were included in the study. The results showed significant improvement in terms of O saturation and heart rate (HR) using the new modified apnea test compared to the common test. Systolic blood pressure, diastolic blood pressure, and the frequency of complications were improved in the new modified test.
The modified apnea test produced better results in terms of O saturation, HR, and other clinical factors, while it does not require disconnection from the ventilator and repeated ABG assessment. Therefore, it can be used to successfully diagnose brain death in high-risk individuals suffering from severe hypoxia.
呼吸暂停测试是确认脑死亡的必要手段;然而,对于没有呼吸机支持就会出现严重低氧血症的患者来说,该测试并不安全。在本研究中,我们使用了一种无需将患者与呼吸机断开连接的新型改良呼吸暂停测试,并将新方法的结果及并发症与广泛使用的旧方法进行了比较。
本研究针对疑似脑死亡的患者开展。新旧呼吸暂停测试均在同一患者身上进行。在新的改良方法中,采用诱导高碳酸血症法,而非过度通气然后将脑死亡患者与呼吸机分离,并且不再进行重复动脉血气分析(ABG),而是获取目标呼气末二氧化碳分压(ETCO),在达到目标ETCO时,同时检查ABG,随后将ETCO与动脉血二氧化碳分压(PaCO)进行比较。
本研究纳入了30例患者,其中男性25例(83.3%),女性5例(16.75%)。结果显示,与常规测试相比,新型改良呼吸暂停测试在血氧饱和度和心率(HR)方面有显著改善。新型改良测试在收缩压、舒张压及并发症发生率方面也有所改善。
改良呼吸暂停测试在血氧饱和度、心率及其他临床因素方面产生了更好的结果,同时无需与呼吸机断开连接以及重复进行ABG评估。因此,它可用于成功诊断患有严重缺氧的高危个体的脑死亡。